FDA Inspection 1265822 — PRIMAL THERAPIES, Inc
The FDA completed an inspection of PRIMAL THERAPIES, Inc on Apr 1, 2025 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 1, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Minneapolis, MN (United States)